Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Global High Flow Oxygen Therapy Devices and Cannula Market: By Flow Rate, 5-40, 1-60 ), By Application, and Geography
Global High Flow Oxygen Therapy Devices and Cannula Market: By Flow Rate, 5-40, 1-60 ), By Application, and Geography
High Flow Oxygen Therapy Devices and Cannula Market size was valued at US$ 1.8 billion in 2023 and is expected to reach US$ x million by 2030, at a CAGR of 6.8% from 2024-2030. Due to the mounting frequency of CPOD and other respiratory diseases. Moreover, the growing elderly population and increasing cases of accidents are also surging the growth of the market. More than 65 million of the population is affected by moderate-to-severe COPD. High-flow oxygen therapy (HFOT) is an innovative and non-invasive approach for the treatment of patients suffering from acute or chronic respiratory failure.
This report studies the market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Study Period
2024-2030Base Year
2023CAGR
6.8%Largest Market
Asia-PacificFastest Growing Market
North-America
The budding incidence of CPOD and other respiratory diseases are fueling the growth of global high flow oxygen therapy devices and cannula market. High flow therapy delivers respiratory gases at a high flow rate to support patients own natural breathing. It does this by generating positive pressure in the airways, aiding to keep them open. Moreover, it also improves the effective exchange of gases (by delivering oxygen and removing carbon dioxide) and makes breathing easier, while releasing patients respiratory muscles. Additionally, it also plays a role in handling dyspnea and hypoxemia. Furthermore, HFNC is used as a first line oxygen treatment to decrease the risk of requiring escalation to NIV or intubation.
North America accounted for larger revenue share in global High Flow Oxygen Therapy Devices and Cannula market with significant CAGR owing to growing number of critical patient cases, increase in research and development for developing new treatment therapies, and better-quality healthcare facilities. Snowballing government support and funding in the research and development is also strengthening the growth of the market in North America. Europe accounted for a weighty share in market due to the growing number of accidents and critical patients survival cases. Asia Pacific is expected to grow suggestively due to their emerging economies, growing elderly population, and technological advancements.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1.8 billion |
|
Market CAGR |
6.8% |
|
By Flow Rate |
|
|
By Application |
|
Download Free Sample Report
The high flow oxygen therapy devices and cannula market size was valued at US$ 1.8 billion in 2023 and is expected to reach US$ x million by 2030, at a CAGR of 6.8% during the forecast period 2024-2030
north-America is the fastest-growing region for the high flow oxygen therapy devices and cannula market
| 1.Executive Summary |
| 2.Global High Flow Oxygen Therapy Devices And Cannula Market Introduction |
| 2.1.Global High Flow Oxygen Therapy Devices And Cannula Market - Taxonomy |
| 2.2.Global High Flow Oxygen Therapy Devices And Cannula Market - Definitions |
| 2.2.1.Flow Rate |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global High Flow Oxygen Therapy Devices And Cannula Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global High Flow Oxygen Therapy Devices And Cannula Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global High Flow Oxygen Therapy Devices And Cannula Market By Flow Rate, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. 1-4 (Liter/Min) |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. 5-40 (Liter/Min) |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. 1-60 (Liter/Min) |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global High Flow Oxygen Therapy Devices And Cannula Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. For CPOD Patients |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. For Critical Care |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. For Neonatal and Pediatric Patients |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global High Flow Oxygen Therapy Devices And Cannula Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America High Flow Oxygen Therapy Devices And Cannula Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Flow Rate Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.1-4 (Liter/Min) |
| 8.1.2.5-40 (Liter/Min) |
| 8.1.3.1-60 (Liter/Min) |
| 8.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.For CPOD Patients |
| 8.2.2.For Critical Care |
| 8.2.3.For Neonatal and Pediatric Patients |
| 8.2.4.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe High Flow Oxygen Therapy Devices And Cannula Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Flow Rate Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.1-4 (Liter/Min) |
| 9.1.2.5-40 (Liter/Min) |
| 9.1.3.1-60 (Liter/Min) |
| 9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.For CPOD Patients |
| 9.2.2.For Critical Care |
| 9.2.3.For Neonatal and Pediatric Patients |
| 9.2.4.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 9.3.7. |
| 10.Asia Pacific (APAC) High Flow Oxygen Therapy Devices And Cannula Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Flow Rate Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.1-4 (Liter/Min) |
| 10.1.2.5-40 (Liter/Min) |
| 10.1.3.1-60 (Liter/Min) |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.For CPOD Patients |
| 10.2.2.For Critical Care |
| 10.2.3.For Neonatal and Pediatric Patients |
| 10.2.4.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) High Flow Oxygen Therapy Devices And Cannula Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Flow Rate Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.1-4 (Liter/Min) |
| 11.1.2.5-40 (Liter/Min) |
| 11.1.3.1-60 (Liter/Min) |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.For CPOD Patients |
| 11.2.2.For Critical Care |
| 11.2.3.For Neonatal and Pediatric Patients |
| 11.2.4.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America High Flow Oxygen Therapy Devices And Cannula Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Flow Rate Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.1-4 (Liter/Min) |
| 12.1.2.5-40 (Liter/Min) |
| 12.1.3.1-60 (Liter/Min) |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.For CPOD Patients |
| 12.2.2.For Critical Care |
| 12.2.3.For Neonatal and Pediatric Patients |
| 12.2.4.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Fisher & Paykel (New Zealand) |
| 13.2.2.Vapotherm (New Hampshire) |
| 13.2.3.Flexicare (UK) |
| 13.2.4.ResMed (California) |
| 13.2.5.Medin (New Jersey) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.